Similar articles

• The Anglo-Scandinavian Cardiac Outcomes Trial-- blood pressure lowering arm.

  Coleman JJ, Kendall MJ. Coleman JJ, et al. J Clin Pharm Ther. 2006 Aug;31(4):299-307. doi: 10.1111/j.1365-2710.2006.00760.x. J Clin Pharm Ther. 2006. PMID: 16882098 Review. No abstract available.
• Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial.

  Gupta AK, Poulter NR, Dobson J, Eldridge S, Cappuccio FP, Caulfield M, Collier D, Cruickshank JK, Sever PS, Feder G; ASCOT. Gupta AK, et al. Am J Hypertens. 2010 Sep;23(9):1023-30. doi: 10.1038/ajh.2010.105. Epub 2010 Aug 19. Am J Hypertens. 2010. PMID: 20725056
• Diabetes and hypertension: which is the best approach?

  Escobar C, Barrios V. Escobar C, et al. Expert Rev Cardiovasc Ther. 2009 Mar;7(3):269-71. doi: 10.1586/14779072.7.3.269. Expert Rev Cardiovasc Ther. 2009. PMID: 19296764
• [ASCOT Study of optimal hypertension therapy. New study results against the "diuretics first" recommendation].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2005 Dec 8;147(49-50):66-7. MMW Fortschr Med. 2005. PMID: 16402454 German. No abstract available.
• Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trial.

  Volpe M, Tocci G. Volpe M, et al. Aging Clin Exp Res. 2005 Aug;17(4 Suppl):46-53. Aging Clin Exp Res. 2005. PMID: 16640173 Review.